Jaap Venema will become Chief Science Officer at the United States Pharmacopeial Convention (USP) on 15 April and Chair of the organisation’s standards-setting body, the Council of Experts, at the beginning of USP’s next five-year cycle on 1 July.
Venema was most recently Therapeutic Area Lead Biotherapeutics, Global Medical Affairs, Biologics Strategy Development, at AbbVie (formerly Abbott Laboratories), where he provided scientific and medical leadership on key aspects of biotherapeutics across all therapeutic areas, including biosimilars and immunogenicity.
Venema's 15-year tenure at Abbott and Solvay (acquired by Abbott in 2010) included leadership roles in immunology medical affairs, international medical development, vaccines development and exploratory target biology.
He will provide overall leadership for USP’s scientific and standards-setting activities and will have management responsibility for more than 150 staff around the world.
Retiring CSO V. Srini Srinivasan, has served USP in many capacities over a distinguished career of more than 30 years.
